Summary

Europe Bio-implants Market is valued at approximately USD 26.56 Billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.12% over the forecast period 2024-2032. Bioimplants are complex medical devices designed to be implanted in the body in order to substitute or aid a biological structure or function. These tools vary greatly in complexity and function, from simple dental implants to sophisticated devices such as pacemakers, artificial joints, and neural implants. One of the key aims of bioimplants is to enhance the quality of life of people with different illnesses or injuries by using implantable devices to restore lost or impaired functions. Often constructed from biocompatible materials to reduce the risk of rejection by the host's immune system. The market is gaining attention due to advancements such as integrating sensors and wireless connections into bioimplants, enabling real-time monitoring of physiological data and remote adjustment. Additionally, the Europe Bio-implants Market is boosted by the use of biocompatible materials in bioimplants, which lower the risk of rejection by the immune system.

Technological improvements, a rise in chronic illnesses, an ageing population and a growing need for less invasive procedures, all are contributing to the growth of the Europe Bio-implants Market. Improvements in technology play a significant role in the development of innovative implants with upgraded capabilities such as built-in sensors and wireless connectivity, increased sophistication and compatibility with the human body. These improvements improve patient outcomes by enabling real-time monitoring and remote adjustments. However, the market faces challenges such as higher cost of bioimplants, stringent regulatory requirements, and potential complications from implant surgeries. The presence of these barriers could limit the accessibility and approval of bioimplants, impacting the growth of the Europe Bio-implants Market as a whole.

The key countries considered for the Europe Bio-implants market study includes UK, Germany, France, Italy, Spain, and Rest of Europe. In Europe Bio-implants Market, Germany stands out as a dominating region in the market in terms of revenue, fueled by advanced healthcare infrastructure, strong R&D capabilities, and high adoption rates of innovative bio-implant technologies. Germany's strategic location within Europe also enhances its position as a key hub for bio-implant manufacturers and suppliers. The region is experiencing rapid growth due to increasing healthcare expenditure, rising awareness about advanced medical treatments, and expanding healthcare facilities. This growth trend is expected to continue, driving further opportunities and competition in the Europe Bio-implants market. The market in the UK, on the other hand, is expected to grow at the fastest rate over the forecast period.

Major market player included in this report are:
Institut Straumann AG
Smith & Nephew plc
Medacta International
Medtronic plc
Alcon, Inc.
Carl Zeiss Meditec AG
Rayner Intraocular Lenses Limited
Mathys AG Bettlach
Waldemar Link GmbH & Co. KG
Biotronik SE & Co. KG
The detailed segments and sub-segment of the market are explained below:

By Type
Dental Bio-implants
Orthopedic Bio-implants
Spinal Bio-implants
Ophthalmology Bio-implants
Cardiovascular Bio-implants
Others
By End User
Hospitals
Speciality Clinics
Ambulatory surgical centres

By Region:
Europe
UK
Germany
France
Spain
Italy
ROE

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

ページTOPに戻る

Table of Contents

Chapter 1. Europe Bio-implants Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. Europe Bio-implants Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Type
2.3.2. By End User
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Europe Bio-implants Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Europe Bio-implants Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Europe Bio-implants Market Size & Forecasts by Type 2022-2032
5.1. Dental Bio-implants
5.2. Orthopedic Bio-implants
5.3. Spinal Bio-implants
5.4. Ophthalmology Bio-implants
5.5. Cardiovascular Bio-implants
5.6. Others
Chapter 6. Europe Bio-implants Market Size & Forecasts by End User 2022-2032
6.1. Hospitals
6.2. Speciality Clinics
6.3. Ambulatory surgical centres
Chapter 7. Europe Bio-implants Market Size & Forecasts by Country 2022-2032
7.1. U.K. Bio-implants Market
7.1.1. Type breakdown size & forecasts, 2022-2032
7.1.2. End User breakdown size & forecasts, 2022-2032
7.2. Germany Bio-implants Market
7.3. France Bio-implants Market
7.4. Spain Bio-implants Market
7.5. Italy Bio-implants Market
7.6. Rest of Europe Bio-implants Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Institut Straumann AG
8.1.2. Smith & Nephew plc
8.1.3. Medacta International
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Institut Straumann AG
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Smith & Nephew plc
8.3.3. Medacta International
8.3.4. Medtronic plc
8.3.5. Alcon, Inc.
8.3.6. Carl Zeiss Meditec AG
8.3.7. Rayner Intraocular Lenses Limited
8.3.8. Mathys AG Bettlach
8.3.9. Waldemar Link GmbH & Co. KG
8.3.10. Biotronik SE & Co. KG
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes